Orexigen Therapeutics, Inc. (NASDAQ:OREX)’s Basic Consolidated EPS Came In At $-0.5238

0

Orexigen Therapeutics, Inc. (NASDAQ:OREX) posted annual consolidated EPS of $-0.5238 for the period ended 2015-12-31. But basic consolidated EPS for the quarter period ended 2015-12-31 came in at $-0.5238.

Basic EPS from continuing operations

The company’s basic EPS from continuing operations for the annual period ended 2015-12-31 came in at $-0.5238 while basic EPS from continuing operations for the three-month period to 2015-12-31 was$-0.5238.

EPS contribution from parent

Orexigen Therapeutics, Inc. (NASDAQ:OREX) received $-0.5238 basic EPS contribution from its parent company in the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, the parent company contributed EPS of $-0.5238.

Basic net EPS

Orexigen Therapeutics, Inc. (NASDAQ:OREX) posted basic net EPS of $-0.52 for the annual period ended 2015-12-31. For the quarter ended 2015-12-31, the company posted basic net EPS of $-0.52.

Consolidated diluted EPS

The company’s consolidated diluted EPS for the period ended 2015-12-31 was $-0.5238 while consolidated diluted EPS was $-0.5238 for the quarter ended 2015-12-31.

Basic diluted EPS

Basic diluted EPS from continuing operation for the annual period ended 2015-12-31 was $-0.5238. As for the quarter, diluted EPS from continuing operations for the three-month ended 2015-12-31 stood at $-0.5238.

Net diluted EPS

Net diluted EPS was $-0.52 for the annual period ended 2015-12-31. But net diluted EPS for the quarterly period ended 2015-12-31 stood at $-0.52.

Diluted EPS from parent

From the parent company, Orexigen Therapeutics, Inc. (NASDAQ:OREX) received diluted EPS of $-0.5238

For the annual period ended 2015-12-31, diluted EPS from Orexigen Therapeutics, Inc. (NASDAQ:OREX)’s parent company was$-0.5238. But for the quarter period ended 2015-12-31, diluted EPS contribution from the parent company was $-0.5238.

Orexigen Therapeutics, Inc. (NASDAQ:OREX)’s net basic EPS for the annual period ended 2015-12-31 was $-0.52 and for the quarter period ended 2015-12-31 it was $-0.52.

For the annual period ended 2015-12-31, the company had average basic shares outstanding of 131.129 while basic shares outstanding were 131.129 for the quarter period ended 2015-12-31.

The company’s diluted shares outstanding was 131.129 for the annual period ended 2015-12-31 is 131.129. That compared with 131.129 diluted shares outstanding for the quarter period ended 2015-12-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 8 times, 1 visits today)